For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

KLOW Blend

A four-component reference that adds KPV to the GLOW combination. More components mean more identity and compatibility checks.

Reference variants

Add KLOW Blend to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 80mg (10/10/10/50)Vial · confirm physical formCAS Multi-component
    $39.68/vial$31.74/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

The listed format combines GHK-Cu, BPC-157, TB-500 and KPV. None of the components is an approved medicine.

What the review will ask

Ask for a specification for each component and the basis for combining them before including the item in a request.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is KLOW simply GLOW with KPV?

That is how the reference describes it. Confirm the exact ratio in writing, since trade-name blends vary between suppliers.

Account for the added KPV component

KLOW's additional KPV component requires its own documentation; it cannot be assumed to share the evidence of a GLOW reference. FDA reports a lack of identified human exposure data for KPV drug products.

Documentation to request

Obtain all four component quantities and identity records. Confirm the ratio rather than using the trade name as a complete specification.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Evidence review before expanding a clinic menu. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale